Tenvir is a brand family of Cipla Ltd., sold in Nepal. The NepalDoc catalog lists 2 Tenvir products across 2 medicine lines: Tenofovir Disoproxil Fumarate, Tenofovir alafenamide.
VEMLIDY is indicated for the treatment of chronic hepatitis B virus (HBV) infection in adults and pediatric patients 6 years of age and older and weighing at least 25 kg with compensated liver disease.
From the U.S. FDA-approved label for Tenofovir alafenamide. Full label: DailyMed.
VEMLIDY is indicated for the treatment of chronic hepatitis B virus (HBV) infection in adults and pediatric patients 6 years of age and older and weighing at least 25 kg with compensated liver disease.
From the U.S. FDA-approved label for Tenofovir alafenamide. Full label: DailyMed.
Testing: Prior to initiation of VEMLIDY, test patients for HIV infection. Prior to or when initiating VEMLIDY, and during treatment on a clinically appropriate schedule, assess serum creatinine, estimated creatinine clearance, urine glucose, and urine protein in all patients. Also assess serum phosphorus in patients with chronic kidney disease.
Directions from the U.S. FDA-approved label for Tenofovir alafenamide — your doctor or pharmacist may advise differently.
HBV and HIV-1 coinfection: VEMLIDY alone is not recommended for the treatment of HIV-1 infection. HIV-1 resistance may develop in these patients. New onset or worsening renal impairment: Prior to or when initiating VEMLIDY, and during treatment on a clinically appropriate schedule, assess serum creatinine, estimated creatinine clearance, urine glucose, and urine protein in all patients. Also assess serum phosphorus in patients with chronic kidney disease.
Warnings and precautions excerpt from the U.S. FDA-approved label for Tenofovir alafenamide — not a complete list. Talk to a pharmacist or doctor before use.
The following adverse reactions are discussed in other sections of the labeling: Severe Acute Exacerbation of Hepatitis B New Onset or Worsening of Renal Impairment Lactic Acidosis/Severe Hepatomegaly with Steatosis Most common adverse reaction (incidence greater than or equal to 10%, all grades) is headache. To report SUSPECTED ADVERSE REACTIONS, contact Gilead Sciences, Inc.
Excerpt from the U.S. FDA-approved label for Tenofovir alafenamide — not a complete list. Talk to a pharmacist or doctor about side effects.
Store below 30 °C (86 °F). Keep container tightly closed. Dispense only in original container.
Storage information from the U.S. FDA-approved label for Tenofovir alafenamide.
What is Tenvir-AF?
Tenvir-AF 25mg Tablet is a Tenofovir alafenamide medicine made by Cipla Ltd. It comes as 25mg Tablet.
What is the generic name of Tenvir-AF?
The generic name of Tenvir-AF is Tenofovir alafenamide.
What are the side effects of Tenofovir alafenamide?
The following adverse reactions are discussed in other sections of the labeling: Severe Acute Exacerbation of Hepatitis B New Onset or Worsening of Renal Impairment Lactic Acidosis/Severe Hepatomegaly with Steatosis Most common adverse reaction (incidence greater than or equal to 10%, all grades) is headache.
What is the price of Tenvir-AF in Nepal?
NepalDoc does not list medicine prices. Prices are set by individual pharmacies in Nepal and change over time — this page confirms the brand sold in Nepal, its generic name, maker, strength and pack details so you can check the price at your pharmacy with confidence.
This page is information only and is not medical advice. Medicine details come from the sources listed above and may change — always confirm the medicine, strength and dose with a pharmacist or doctor before use. A catalog listing does not guarantee that a medicine is in stock at any pharmacy.
Every NepalDoc section, one tap away.